2297 related articles for article (PubMed ID: 12456994)
1. SVR angiosarcomas can be rejected by CD4 costimulation dependent and CD8 costimulation independent pathways.
Arbiser JL; Bingaman A; Durham M; Cowan S; Cohen C; Zarnegar E; Varma V; Larsen CP
Mol Med; 2002 Sep; 8(9):551-8. PubMed ID: 12456994
[TBL] [Abstract][Full Text] [Related]
2. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
3. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
4. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
[TBL] [Abstract][Full Text] [Related]
5. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
Yen MH; Lepak N; Swain SL
J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
[TBL] [Abstract][Full Text] [Related]
6. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation.
Zhan Y; Corbett AJ; Brady JL; Sutherland RM; Lew AM
J Immunol; 2000 Oct; 165(7):3612-9. PubMed ID: 11034363
[TBL] [Abstract][Full Text] [Related]
7. The role of CD40 ligand in costimulation and T-cell activation.
Grewal IS; Flavell RA
Immunol Rev; 1996 Oct; 153():85-106. PubMed ID: 9010720
[TBL] [Abstract][Full Text] [Related]
8. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells.
Eck SC; Turka LA
Cancer Immunol Immunother; 1999 Sep; 48(6):336-41. PubMed ID: 10473809
[TBL] [Abstract][Full Text] [Related]
9. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
Liu H; Qiu F; Wang Y; Zeng Q; Liu C; Chen Y; Liang CL; Zhang Q; Han L; Dai Z
Front Immunol; 2019; 10():306. PubMed ID: 30863408
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous blockade of B7-CD28 and CD40-CD40L costimulation eliminates the direct xenorestricted human anti-porcine T-cell response.
Popma SH; Krasinskas AM; Kreisel D; Szeto W; McLean AD; Moore JS; Rosengard BR
Transplant Proc; 2001; 33(1-2):767-9. PubMed ID: 11267061
[No Abstract] [Full Text] [Related]
11. On CD28/CD40 ligand costimulation, common gamma-chain signals, and the alloimmune response.
Demirci G; Gao W; Zheng XX; Malek TR; Strom TB; Li XC
J Immunol; 2002 May; 168(9):4382-90. PubMed ID: 11970980
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
DiPaolo RJ; Unanue ER
J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
[TBL] [Abstract][Full Text] [Related]
13. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells.
Chambers CA; Sullivan TJ; Allison JP
Immunity; 1997 Dec; 7(6):885-95. PubMed ID: 9430233
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade.
Coenen JJ; Koenen HJ; van Rijssen E; Boon L; Joosten I; Hilbrands LB
J Immunol; 2006 May; 176(9):5240-6. PubMed ID: 16621989
[TBL] [Abstract][Full Text] [Related]
15. Disruption of CD40/CD40L interaction influences the course of Cryptococcus neoformans infection.
Pietrella D; Lupo P; Perito S; Mosci P; Bistoni F; Vecchiarelli A
FEMS Immunol Med Microbiol; 2004 Jan; 40(1):63-70. PubMed ID: 14734188
[TBL] [Abstract][Full Text] [Related]
16. Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo.
Ronchese F; Hausmann B; Hubele S; Lane P
J Exp Med; 1994 Mar; 179(3):809-17. PubMed ID: 8113677
[TBL] [Abstract][Full Text] [Related]
17. Different costimulatory and growth factor requirements for CD4+ and CD8+ T cell-mediated rejection.
Vu MD; Amanullah F; Li Y; Demirci G; Sayegh MH; Li XC
J Immunol; 2004 Jul; 173(1):214-21. PubMed ID: 15210777
[TBL] [Abstract][Full Text] [Related]
18. Role of CD28/CD80-86 and CD40/CD154 costimulatory interactions in host defense to primary herpes simplex virus infection.
Edelmann KH; Wilson CB
J Virol; 2001 Jan; 75(2):612-21. PubMed ID: 11134274
[TBL] [Abstract][Full Text] [Related]
19. CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells.
Hu HM; Winter H; Ma J; Croft M; Urba WJ; Fox BA
J Immunol; 2002 Nov; 169(9):4897-904. PubMed ID: 12391201
[TBL] [Abstract][Full Text] [Related]
20. Treatment of autoimmunity by inhibition of T cell costimulation.
Daikh DI; Wofsy D
Adv Exp Med Biol; 2001; 490():113-7. PubMed ID: 11505969
[No Abstract] [Full Text] [Related]
[Next] [New Search]
